Why These 2 Under-The-Radar Biotech Stocks Are Poised To Dominate This Year And Beyond

The two small-cap biotech stocks highlighted in today’s article appear poised to dominate this year and beyond. Why? As the author explains, “Both companies are pioneers in their respective spaces and offer robust pipelines, with lead products nearing the middle of the drug-development process.” For more on these two under-the-radar biotech stocks – and the science and potential related to their products – CLICK HERE.